Clinical and metabolic features of polycystic ovary syndrome
- PMID: 17368460
- DOI: 10.1016/j.ijgo.2007.01.005
Clinical and metabolic features of polycystic ovary syndrome
Abstract
Objective: To explore the clinical and metabolic features of Chinese women with polycystic ovary syndrome (PCOS).
Methods: The clinical data of 273 Chinese women diagnosed as having PCOS were retrospectively studied.
Results: Of these women 34.8% had hirsutism, 45.1% had acne, 94.1% had some menstrual abnormality, and 96.7% had typical appearances of polycystic ovaries on ultrasonographic examination. The prevalence of overweight women was 30.4%, and the prevalence of insulin resistance was 12.8% using the glucose to insulin ratio (GIR) and 21.6% using the homesostasis model assessment (HOMA). Body mass index was significantly correlated with fasting insulin level (r=0.50), GIR (r=0.37) and HOMA (r=0.53).
Conclusion: Menstrual abnormality and polycystic ovaries were the main clinical manifestations in this cohort of Chinese women with PCOS. The prevalence of hyperandrogenism, obesity, and insulin resistance was lower in this cohort than in women from other races with the same condition. Ethnic differences needs to be considered when studying the clinical and metabolic features of women with PCOS.
Similar articles
-
Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.J Pediatr Adolesc Gynecol. 2012 Dec;25(6):390-5. doi: 10.1016/j.jpag.2012.07.006. Epub 2012 Oct 22. J Pediatr Adolesc Gynecol. 2012. PMID: 23089573
-
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.Hum Reprod. 2008 Aug;23(8):1924-31. doi: 10.1093/humrep/den239. Epub 2008 Jun 24. Hum Reprod. 2008. PMID: 18579512
-
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.Neuro Endocrinol Lett. 2007 Dec;28(6):807-10. Neuro Endocrinol Lett. 2007. PMID: 18063948
-
Polycystic ovary syndrome and type 2 diabetes mellitus.Minerva Ginecol. 2004 Feb;56(1):53-62. Minerva Ginecol. 2004. PMID: 14973410 Review.
-
Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.Gynecol Endocrinol. 2016;32(3):177-83. doi: 10.3109/09513590.2015.1111327. Epub 2015 Nov 20. Gynecol Endocrinol. 2016. PMID: 26502288 Review.
Cited by
-
Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare.Reprod Biol Endocrinol. 2012 Nov 22;10:96. doi: 10.1186/1477-7827-10-96. Reprod Biol Endocrinol. 2012. PMID: 23173761 Free PMC article.
-
Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age.Endocr Connect. 2020 Feb;9(2):74-89. doi: 10.1530/EC-19-0496. Endocr Connect. 2020. PMID: 31905164 Free PMC article.
-
Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center.Cureus. 2021 Dec 22;13(12):e20593. doi: 10.7759/cureus.20593. eCollection 2021 Dec. Cureus. 2021. PMID: 35103169 Free PMC article.
-
Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome.Wien Klin Wochenschr. 2010 Sep;122(17-18):519-24. doi: 10.1007/s00508-010-1426-x. Epub 2010 Sep 3. Wien Klin Wochenschr. 2010. PMID: 20809108
-
Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome.Rev Bras Ginecol Obstet. 2022 Feb;44(2):142-153. doi: 10.1055/s-0041-1741030. Epub 2022 Feb 25. Rev Bras Ginecol Obstet. 2022. PMID: 35213912 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical